Genomics

ASHG recently spoke with Julie Gerberding, MD, MPH, President and CEO of the Foundation for the National Institutes of Health (FNIH), on how this organization leverages expertise across a breadth of scientific industries to address complex health challenges and accelerate research, particularly in human genetics and genomics.  The FNIH is an independent, not-for-profit 501(c)(3) charitable... Read More

ASHG recently responded to a select number of questions in a Request for Information (RFI) from the White House Office of Science and Technology Policy (OSTP) on the National Biotechnology and Biomanufacturing Initiative. OSTP released this RFI to seek public input on how advances in biotechnology and biomanufacturing can help support a strong bioeconomy. The insights... Read More

Advances in human genetics & genomics have led to a better understanding of the fundamental biology of sensory systems and inform effective and accessible treatments to improve quality of life. Debara Tucci, MD, MS, MBA, leads the National Institute on Deafness and Other Communication Disorders’ (NIDCD) research and research training programs in hearing, balance, taste,... Read More

We recently spoke with Geoffrey Ginsburg, MD, PhD, Chief Medical and Scientific Officer at All of Us, who leads the effort to set the scientific vision and strategy for the program as well as oversees the program’s collection and curation of data and the integration of new data types. All of Us is a precision... Read More

On April 4, 2022, the National Academies of Sciences, Engineering, and Medicine (NASEM)’s Committee on Use of Race, Ethnicity, and Ancestry as Population Descriptors in Genomics Research (“the Committee”) held a virtual public workshop as part of its work to prepare a report on this topic, which will be published in early 2023. ASHG President... Read More